Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options

 
 


In connection with the New York Times’ recent coverage of hormone therapy1, Pfizer Inc. released important facts and context to respond to the newspaper’s account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines. Premarin (conjugated estrogens tablets USP) and Prempro (conjugated estrogens/medroxyprogesterone acetate tablets), which are approved by the Food and Drug Administration (FDA), have brought relief to tens of millions of women for decades…


Go to Source

People who read this also read

Write a Comment

Gravatars are small images that can show your personality. You can get your gravatar for free today!

Copyright © 2010 Procto Med. All rights reserved.